HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seung-Woon Rha Selected Research

Ezetimibe (Zetia)

12/2023Moderate-intensity statin plus ezetimibe vs high-intensity statin according to baseline LDL-C in the treatment of atherosclerotic cardiovascular disease: A post-hoc analysis of the RACING randomized trial.
11/2023Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis.
1/2022Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial.
12/2019Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering Efficacy.
1/2018A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial.
12/2016Clinical outcome of statin plus ezetimibe versus high-intensity statin therapy in patients with acute myocardial infarction propensity-score matching analysis.
10/2016Effect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seung-Woon Rha Research Topics

Disease

114Myocardial Infarction
05/2024 - 06/2004
63Cardiovascular Diseases (Cardiovascular Disease)
02/2024 - 06/2005
54Thrombosis (Thrombus)
05/2024 - 04/2004
38Coronary Artery Disease (Coronary Atherosclerosis)
04/2024 - 09/2004
31Death (Near-Death Experience)
05/2024 - 04/2010
28Hemorrhage
10/2023 - 04/2004
27ST Elevation Myocardial Infarction
01/2024 - 06/2009
24Diabetes Mellitus
10/2023 - 05/2010
23Stroke (Strokes)
12/2023 - 04/2010
18Coronary Vasospasm (Coronary Artery Vasospasm)
03/2023 - 11/2009
16Hypertension (High Blood Pressure)
07/2023 - 10/2011
15Heart Failure
06/2023 - 01/2015
14Spasm (Spasms)
05/2023 - 10/2007
13Chest Pain (Chest Pains)
02/2024 - 02/2007
13Non-ST Elevated Myocardial Infarction
01/2024 - 01/2016
13Acute Coronary Syndrome
10/2023 - 09/2015
12Pathologic Constriction (Stenosis)
05/2023 - 08/2005
12Atrial Fibrillation
01/2021 - 04/2011
10Coronary Stenosis (Coronary Artery Stenosis)
02/2024 - 08/2007
7Coronary Disease (Coronary Heart Disease)
01/2020 - 02/2007
6Dyslipidemias (Dyslipidemia)
02/2024 - 06/2010
5Atherosclerosis
11/2023 - 01/2004
5Essential Hypertension
03/2021 - 10/2011
5Chronic Renal Insufficiency
01/2021 - 06/2016
5Hyperlipidemias (Hyperlipidemia)
10/2020 - 03/2012
5Hypercholesterolemia
12/2019 - 10/2016
4Chronic Limb-Threatening Ischemia
10/2023 - 03/2015
4Left Ventricular Dysfunction
11/2021 - 11/2010
4Peripheral Arterial Disease
01/2021 - 11/2009
4Hematoma
01/2020 - 04/2004
4Inflammation (Inflammations)
11/2015 - 04/2011
3Ischemia
05/2024 - 07/2012
3Type 2 Diabetes Mellitus (MODY)
02/2024 - 10/2005
3Ischemic Stroke
10/2023 - 08/2010
3Obesity
06/2023 - 10/2005
3Cardiac Arrhythmias (Arrythmia)
06/2022 - 04/2011
3Insulin Resistance
01/2020 - 02/2013
3Infarction (Infarctions)
12/2019 - 05/2008
3Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2016 - 04/2004
2Hyperuricemia
02/2024 - 01/2015
2Drug-Related Side Effects and Adverse Reactions
01/2023 - 01/2018
2Rupture
01/2022 - 04/2013
2Hypotension (Low Blood Pressure)
10/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

58omega-Chloroacetophenone (Mace)IBA
02/2024 - 06/2005
22Acetylcholine (Acetylcholine Chloride)FDA Link
02/2024 - 10/2007
18Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2023 - 01/2010
17Clopidogrel (Plavix)FDA Link
11/2023 - 02/2006
15Sirolimus (Rapamycin)FDA Link
04/2024 - 08/2005
14Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2024 - 02/2007
10Rosuvastatin Calcium (Crestor)FDA Link
12/2023 - 03/2012
9EverolimusFDA Link
05/2024 - 07/2012
9Paclitaxel (Taxol)FDA LinkGeneric
05/2024 - 02/2006
8NitratesIBA
02/2024 - 10/2016
82'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
11/2022 - 01/2016
8LipidsIBA
10/2020 - 01/2009
7Cilostazol (Pletal)FDA LinkGeneric
05/2024 - 08/2009
7Ezetimibe (Zetia)FDA Link
12/2023 - 10/2016
7C-Reactive ProteinIBA
07/2019 - 05/2008
6PolymersIBA
04/2024 - 09/2015
6oxidized low density lipoproteinIBA
12/2023 - 01/2010
6Antihypertensive Agents (Antihypertensives)IBA
01/2023 - 06/2010
6LDL CholesterolIBA
01/2022 - 01/2010
6CholesterolIBA
01/2022 - 01/2009
5Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2023 - 12/2017
5Angiotensin Receptor AntagonistsIBA
07/2023 - 12/2017
5Heparin (Liquaemin)FDA LinkGeneric
01/2021 - 04/2004
5Phenobarbital (Luminal)FDA Link
10/2019 - 11/2009
5bivalirudin (Angiomax)FDA Link
10/2005 - 04/2004
4Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2011
4zotarolimusIBA
11/2015 - 12/2009
3Uric Acid (Urate)IBA
02/2024 - 01/2018
3Prasugrel HydrochlorideFDA Link
10/2023 - 09/2015
3DiamondIBA
06/2023 - 06/2016
3BESIBA
01/2023 - 09/2015
3MetalsIBA
01/2023 - 02/2007
3Ergonovine (Ergometrine)IBA
01/2022 - 02/2018
3Atorvastatin (Lipitor)FDA Link
01/2021 - 04/2015
3pitavastatin (itavastatin)FDA Link
10/2020 - 12/2011
3Insulin (Novolin)FDA Link
01/2020 - 04/2004
3Blood Glucose (Blood Sugar)IBA
01/2020 - 06/2014
3Calcium Channel Blockers (Blockers, Calcium Channel)IBA
11/2019 - 04/2018
3Triglycerides (Triacylglycerol)IBA
01/2019 - 12/2011
3CreatinineIBA
01/2018 - 08/2010
3Lipoprotein(a)IBA
01/2018 - 05/2008
2Particulate MatterIBA
01/2024 - 01/2021
2Angiotensin II Type 1 Receptor BlockersIBA
07/2023 - 01/2020
2Vasodilator Agents (Vasodilators)IBA
05/2023 - 01/2022
2TicagrelorIBA
11/2021 - 01/2021
2Indicators and Reagents (Reagents)IBA
05/2020 - 01/2020
2Celecoxib (Celebrex)FDA Link
01/2020 - 11/2012

Therapy/Procedure

81Stents
05/2024 - 08/2005
76Percutaneous Coronary Intervention
05/2024 - 04/2004
53Drug-Eluting Stents
05/2024 - 04/2004
53Therapeutics
02/2024 - 01/2005
16Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2023 - 06/2004
9Catheter Ablation
12/2020 - 04/2011
5Surgical Amputation (Amputations)
10/2023 - 03/2015
2Patient Readmission
01/2023 - 10/2020
2Cardiac Rehabilitation
12/2021 - 01/2020
2Secondary Prevention
01/2021 - 02/2013